Active substances and pharmaceuticals concerned
| Name of active substance | Trade name | Affected micronutrients |
| L-Thyroxin | Euthyrox®, Thyrex® | Selenium Iron Calcium |
| Name of active substance | Trade name | Affected micronutrients |
| L-Thyroxin | Euthyrox®, Thyrex® | Selenium Iron Calcium |
| Mechanism of interaction | |
| Selenium | Selenium, as cofactor of glutathione peroxidases and deiodinases, optimizes thyroid hormone metabolism. Additionally, lipid peroxidation is inhibited and TSH levels are reduced. |
| Iron Calcium |
When taken simultaneously, complex formation occurs and therefore the effect of the drug is reduced. |
| Negative consequences of the interaction | Possible symptoms | |
| Iron Calcium |
Complex formation |
|
| Positive consequences of the interaction | Possible symptoms | |
| Selenium | Effect optimization |
|
| Medical substance | Recommended supplementation | Dosage |
| L-Thyroxin | Sodium Selenite | 200-300 µg/d p.o. |
| Instructions for use | ||
| Iron Calcium |
A minimum interval of one to two hours between drug and supplement intake is recommended. | |
| References |
|
A Irving S et al. Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol (Oxf). 2014 Jul 17. doi: 10.1111/cen.12559. |